Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade - PubMed (original) (raw)
Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade
F Galbiati et al. EMBO J. 1998.
Abstract
Caveolin-1 is a principal component of caveolae membranes in vivo. Caveolin-1 mRNA and protein expression are lost or reduced during cell transformation by activated oncogenes. Interestingly, the human caveolin-1 gene is localized to a suspected tumor suppressor locus (7q31.1). However, it remains unknown whether downregulation of caveolin-1 is sufficient to mediate cell transformation or tumorigenicity. Here, we employ an antisense approach to derive stable NIH 3T3 cell lines that express dramatically reduced levels of caveolin-1 but contain normal amounts of caveolin-2. NIH 3T3 cells harboring antisense caveolin-1 exhibit anchorage-independent growth, form tumors in immunodeficient mice and show hyperactivation of the p42/44 MAP kinase cascade. Importantly, transformation induced by caveolin-1 downregulation is reversed when caveolin-1 protein levels are restored to normal by loss of the caveolin-1 antisense vector. In addition, we show that in normal NIH 3T3 cells, caveolin-1 expression levels are tightly regulated by specific growth factor stimuli and cell density. Our results suggest that upregulation of caveolin-1 may be important in mediating contact inhibition and negatively regulating the activation state of the p42/44 MAP kinase cascade.
Similar articles
- Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain.
Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, Lisanti MP. Engelman JA, et al. FEBS Lett. 1998 May 29;428(3):205-11. doi: 10.1016/s0014-5793(98)00470-0. FEBS Lett. 1998. PMID: 9654135 - Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts.
Volonte D, Zhang K, Lisanti MP, Galbiati F. Volonte D, et al. Mol Biol Cell. 2002 Jul;13(7):2502-17. doi: 10.1091/mbc.01-11-0529. Mol Biol Cell. 2002. PMID: 12134086 Free PMC article. - Caveolin-1 in breast cancer.
Bouras T, Lisanti MP, Pestell RG. Bouras T, et al. Cancer Biol Ther. 2004 Oct;3(10):931-41. doi: 10.4161/cbt.3.10.1147. Epub 2004 Oct 28. Cancer Biol Ther. 2004. PMID: 15539932 Review. - Caveolin-1 in oncogenic transformation, cancer, and metastasis.
Williams TM, Lisanti MP. Williams TM, et al. Am J Physiol Cell Physiol. 2005 Mar;288(3):C494-506. doi: 10.1152/ajpcell.00458.2004. Am J Physiol Cell Physiol. 2005. PMID: 15692148 Review.
Cited by
- NF1-dependent disruption of the blood-nerve-barrier is improved by blockade of P2RY14.
Patritti-Cram J, Rahrmann EP, Rizvi TA, Scheffer KC, Phoenix TN, Largaespada DA, Ratner N. Patritti-Cram J, et al. iScience. 2024 Jun 17;27(7):110294. doi: 10.1016/j.isci.2024.110294. eCollection 2024 Jul 19. iScience. 2024. PMID: 39100928 Free PMC article. - Unraveling the Cave: A Seventy-Year Journey into the Caveolar Network, Cellular Signaling, and Human Disease.
D'Alessio A. D'Alessio A. Cells. 2023 Nov 22;12(23):2680. doi: 10.3390/cells12232680. Cells. 2023. PMID: 38067108 Free PMC article. Review. - PET and Optical Imaging of Caveolin-1 in Gastric Tumors.
Surendra Panikar S, Shmuel S, Lewis JS, Pereira PMR. Surendra Panikar S, et al. ACS Omega. 2023 Sep 15;8(39):35884-35892. doi: 10.1021/acsomega.3c03614. eCollection 2023 Oct 3. ACS Omega. 2023. PMID: 37810678 Free PMC article. - The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications.
Szewczyk-Roszczenko OK, Roszczenko P, Shmakova A, Finiuk N, Holota S, Lesyk R, Bielawska A, Vassetzky Y, Bielawski K. Szewczyk-Roszczenko OK, et al. Cells. 2023 Sep 19;12(18):2312. doi: 10.3390/cells12182312. Cells. 2023. PMID: 37759535 Free PMC article. Review. - The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy.
Xia W, Li X, Wu Q, Xu A, Zhang L, Xia Z. Xia W, et al. Front Immunol. 2022 Nov 2;13:951381. doi: 10.3389/fimmu.2022.951381. eCollection 2022. Front Immunol. 2022. PMID: 36405687 Free PMC article. Review.
References
- J Cell Biol. 1992 Sep;118(5):1003-14 - PubMed
- Oncogene. 1996 Oct 17;13(8):1815-8 - PubMed
- Genes Chromosomes Cancer. 1998 Feb;21(2):152-9 - PubMed
- J Biol Chem. 1998 Mar 6;273(10):5419-22 - PubMed
- Oncogene. 1998 Mar;16(11):1391-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources